BioMimir
BioMimir is a B2B medical device company specializing in regenerative technology, focusing on purpose-designed biomimetic polymers for next-generation tissue regeneration. They develop affordable, scalable, and globally deployable solutions for wound healing, inspired by nature to replicate the structure and function of features in plants, animals, and human tissues. Their core innovation involves anti-inflammatory and pro-regenerative biomimetic polymers that mimic the body's extracellular matrix, aiming to prevent scar tissue and enhance clinical outcomes.
Industries
Nr. of Employees
small (1-50)
BioMimir
Québec: 7-2650 rue Maximilien-Chagnon, Sherbrooke, QC, Canada J1E 0M8; Alberta: 3655 36 Street NW, Calgary, AB, Canada T2L 1Y8
Products
Bioresorbable liquid-to-solid wound filler (lead development candidate)
A bioresorbable skin substitute concept that transitions from liquid to solid in situ to fill complex wounds and reduce scarring; described as the company's proof-of-concept lead candidate for treatment of ulcers, abscesses, and fistulas.
Bioresorbable liquid-to-solid wound filler (lead development candidate)
A bioresorbable skin substitute concept that transitions from liquid to solid in situ to fill complex wounds and reduce scarring; described as the company's proof-of-concept lead candidate for treatment of ulcers, abscesses, and fistulas.
Services
Development and provision of regenerative biomaterial solutions for business customers, including design and manufacture of biomimetic polymer products for wound treatment.
Collaborative R&D and translational research support for biomaterials development, including preclinical proof-of-concept studies and publication-driven research.
Development and provision of regenerative biomaterial solutions for business customers, including design and manufacture of biomimetic polymer products for wound treatment.
Collaborative R&D and translational research support for biomaterials development, including preclinical proof-of-concept studies and publication-driven research.
Expertise Areas
- Regenerative medicine
- Biomaterials and polymer chemistry
- Wound care device development
- Medical device manufacturing and quality systems (ISO 13485 familiarity)
Key Technologies
- Biomimetic polymer design
- Bioresorbable polymer formulations
- Liquid-to-solid wound filler systems
- Extracellular matrix-mimicking materials
News & Updates
BioMimir is honoured with a CIX Startup Award in the Emerging Category.
BioMimir announced it will present at Biotech Showcase™ 2024, showcasing products MatriFlex and MatriSoothe, planned to go to market in 2025.
BioMimir announced its graduation from the 2022/2023 Biomedical Engineering stream of the CDL program at UBC, with a focus on biomaterials for complex wounds.
BioMimir was recognized with a CIX Startup Award in the Emerging Category.
BioMimir was selected to join the MedTech Innovator 2025 Accelerator Cohort, one of only 65 companies from nearly 1,500 applicants, to accelerate its growth in regenerative medicine.
Tips for teenage innovators to get involved in STEM today.
BioMimir is honoured with a CIX Startup Award in the Emerging Category.
BioMimir announced it will present at Biotech Showcase™ 2024, showcasing products MatriFlex and MatriSoothe, planned to go to market in 2025.
BioMimir announced its graduation from the 2022/2023 Biomedical Engineering stream of the CDL program at UBC, with a focus on biomaterials for complex wounds.
BioMimir was recognized with a CIX Startup Award in the Emerging Category.
BioMimir was selected to join the MedTech Innovator 2025 Accelerator Cohort, one of only 65 companies from nearly 1,500 applicants, to accelerate its growth in regenerative medicine.
Tips for teenage innovators to get involved in STEM today.